Allied Healthcare Products
AHPI
AHPI was delisted on the 2nd of February, 2023.
11 hedge funds and large institutions have $114K invested in Allied Healthcare Products in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
1.03% less ownership
Funds ownership: 4.15% → 3.12% (-1%)
8% less funds holding
Funds holding: 12 → 11 (-1)
66% less capital inflows, than outflows
Capital inflows: $13.3K | Capital outflows: $39.1K
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$8.79K |
| 2 |
Tower Research Capital (TRC)
New York
|
+$3.86K |
| 3 |
U.S. Capital Wealth Advisors
Austin,
Texas
|
+$589 |
| 4 |
Hanson & Doremus Investment Management
Burlington,
Vermont
|
+$18 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19.6K |
| 2 |
Thompson Davis & Co
Richmond,
Virginia
|
-$17K |
| 3 |
Renaissance Technologies
New York
|
-$2K |
| 4 |
Schonfeld Strategic Advisors
New York
|
-$471 |
AHPI Hedge Fund Activity: Q4 2022 in Review
11 of the 6,243 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q4 2022, worth a combined $114K — down 48% from $220K a quarter earlier.
Fund positioning in AHPI was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $8.79K. The largest seller was Vanguard Group, cutting an estimated $19.6K.
- 11 institutional investors held Allied Healthcare Products (AHPI) as of Q4 2022, down from 12 in Q3 2022.
- Funds reported $114K of Allied Healthcare Products stock for Q4 2022, down 48% quarter-over-quarter.
- 3 funds opened new Allied Healthcare Products positions in Q4 2022 and 3 closed out, a net change of 0 holders.
- The largest Allied Healthcare Products buyer in Q4 2022 was UBS Group, an estimated $8.79K added.
- The largest Allied Healthcare Products seller in Q4 2022 was Vanguard Group, an estimated $19.6K sold.
Based on aggregated 13F filings for Q4 2022.